Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Arthritis Care & Research|July 27, 2012
Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patientsJeffrey R Curtis, Fenglong Xie, Lang Chen, et al.
Arthritis and Rheumatism|March 6, 2013
Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.
Arthritis and Rheumatism|October 12, 2012
Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseasesKevin Haynes, Timothy Beukelman, Jeffrey R Curtis, et al.
Arthritis and Rheumatism|May 10, 2012
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatmentTimothy Beukelman, Fenglong Xie, Lang Chen, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2023
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learnedTimothy Beukelman, Lang Chen, Narender Annapureddy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2016
A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic LymphohistiocytosisMingce Zhang, Claudia Bracaglia, Giusi Prencipe, et al.
JAMA Dermatology|October 29, 2015
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin CancerFrank I Scott, Ronac Mamtani, Colleen M Brensinger, et al.
Arthritis Care & Research|September 16, 2010
Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritisDaniel J Lovell, Murray H Passo, Timothy Beukelman, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) studyJohn W Baddley, Kevin L Winthrop, Lang Chen, et al.
JAMA|March 7, 2013
Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zosterKevin L Winthrop, John W Baddley, Lang Chen, et al.
Pageof 13